Pegylated interferon and Ribavirin for the treatment of HCV infected patients who failed previous interferon therapy

被引：0
|
作者：
Gaglio, PJ [1 ]
Regenstein, FG [1 ]
Vlacos, MN [1 ]
Bartholomew, D [1 ]
Randazzo, P [1 ]
机构：
[1] Tulane Univ, Sch Med, New Orleans, LA 70112 USA
来源：
GASTROENTEROLOGY | 2001年 / 120卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1969
引用
收藏
页码：A384 / A384
页数：1
相关论文
共 50 条
  • [1] Pegylated interferon and ribavirin for the treatment of HCV infected patients who failed previous therapy.
    Gaglio, PJ
    Regenstein, F
    Bartholomew, D
    Vlacos, M
    HEPATOLOGY, 2001, 34 (04) : 577A - 577A
  • [2] Pegylated interferon and Ribavirin for the treatment of HCV patients who failed prior therapy: Racial and genotype differences
    Gaglio, PJ
    Brown, MJ
    Brown, RS
    GASTROENTEROLOGY, 2002, 123 (01) : 73 - 73
  • [3] TMC435 IN PATIENTS INFECTED WITH HCV GENOTYPE 1 WHO HAVE FAILED PREVIOUS PEGYLATED INTERFERON/RIBAVIRIN TREATMENT: VIROLOGIC ANALYSES OF THE ASPIRE TRIAL
    Lenz, O.
    Fevery, B.
    Vijgen, L.
    Verbeeck, J.
    Peeters, M.
    Beumont-Mauviel, M.
    Zeuzem, S.
    Picchio, G.
    JOURNAL OF HEPATOLOGY, 2012, 56 : S5 - S5
  • [4] TMC435 in Patients Infected with HCV Genotype 1 Who Have Failed Previous Pegylated Interferon/Ribavirin Treatment: Virologic Analyses of The ASPIRE Trial
    Picchio, Gaston
    Lenz, Oliver
    Fevery, Bart
    Vijgen, Leen
    Verbeeck, Jannick
    Peeters, Monika
    Beumont-Mauviel, Maria
    Zeuzem, Stefan
    GASTROENTEROLOGY, 2012, 142 (05) : S145 - S145
  • [5] Pegylated Interferon (alpha-2B) and ribavirin (Rebetol) for the treatment of HCV infected patients who failed prior therapy: Sustained response data
    Gaglio, PJ
    Choi, J
    Zimmerman, D
    Heller, L
    Brown, RS
    GASTROENTEROLOGY, 2004, 126 (04) : A721 - A721
  • [6] Treatment with pegylated interferon alpha 2B and ribavirin produces significant sustained virologic response rates in HCV infected patients who failed prior therapy
    Gaglio, PJ
    Brown, M
    Zimmerman, D
    Choi, J
    Heiler, L
    Brown, R
    GASTROENTEROLOGY, 2003, 124 (04) : A767 - A767
  • [7] Pegylated interferon alpha 2b and Ribavirin for HCV infected patients who failed prior therapy: Interim sustained response data.
    Gaglio, PJ
    Brown, M
    Zimmerman, D
    Choi, J
    Dove, L
    Brown, RS
    HEPATOLOGY, 2002, 36 (04) : 575A - 575A
  • [8] Thymosin Alpha-1 in Combination with Pegylated Interferon and Ribavirin in Chronic Hepatitis C Patients Who have Failed to Prior Pegylated Interferon and Ribavirin Treatment
    Baek, Yang Hyun
    Lee, Sung Wook
    Yoo, Hyun Seung
    Yoon, Hyun Ah
    Kim, Ja Won
    Kim, Young Hoon
    Kim, Ha Youn
    Han, Sang Young
    GUT AND LIVER, 2007, 1 (01) : 87 - 89
  • [9] Final results of pilot study evaluating safety, viral clearance and antifibrotic efficacy of treatment with interferon γ1b+an interferon α plus ribavirin in HCV patients who failed prior pegylated interferon plus ribavirin therapy
    Balan, Vijayan
    Braaten, Julie
    Rosati, Marianne
    Williams, James
    Noble, Brie
    Anderson, Machiko
    Hentz, Joseph
    Rakela, Jorge
    Blatt, Lawrence M.
    HEPATOLOGY, 2006, 44 (04) : 611A - 611A
  • [10] Association of interferon signaling pathway and interferon stimulated genes with response to pegylated interferon and ribavirin therapy in HCV infected Caucasian and African American patients
    Su, Xiaowen
    Rhodes, Shannon
    Yee, Leland
    Im, Kyungah
    Tong, Xiaomei
    Howell, Charles
    Haritos, Marika
    Liang, T. Jake
    Taylor, Milton W.
    Yang, Huiying
    GASTROENTEROLOGY, 2006, 130 (04) : A748 - A748
12345